Background: The prognosis of patients with curatively resectable hepatocell
ular carcinoma depends mainly on anatomic extent of the tumour and on the g
eneral condition of the patient. Given the growing evidence that proliferat
ion indices may be of prognostic significance in hepatocellular carcinomas,
identification and quantitation of proliferative capacity may be of progno
stic importance.
Methods: We have compared four different methods to assess proliferation in
a series of 193 curatively (RO-) resected hepatocellular carcinomas: Mitot
ic count, immunohistochemical assessment of the MIB-1- (Ki-67-), Antigen Pr
oliferating Cell Nuclear Antigen (PCNA) and silverstained nucleolar organis
er regions (AgNOR). The results obtained were compared with pathohistologic
al stage (according to UICC), Edmondson Grade and with survival rate.
Results: In each carcinoma, we could demonstrate mitotic figures, MIB-1, PC
NA and AgNOR dots in variable proportions. Significant statistical correlat
ions were seen between Mitotic Index, the rate of nuclear positivity for MI
B-1 and PCNA and the number of AgNOR dots. In univariate survival analysis
tumour stage and Edmondson Grade, Mitotic Index, MIB-1 and PCNA Index and m
ean AgNOR-number were significant patients' survival influencing factors. P
erforming multivariate Cox survival analysis, Mitotic Index, concomitant ci
rrhosis, Edmondson Grade and patient age were the only significant independ
ent prognostic factors.
Conclusion: These results indicated that Mitotic Index is an additional pro
gnostic parameter which could provide auxiliary information for patients' o
utcome.